Nomura Holdings
MREO

Nomura Holdings’s Mereo BioPharma MREO Stock Holding History

Nomura Holdings’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.2K Buy
+104,361
New +$31.3K ﹤0.01% 1755
2025
Q4 		– Sell
-103,800
Closed -$214K – 2063
2025
Q3 		$214K Sell
103,800
-21,200
-17% -$39.1K ﹤0.01% 1772
2025
Q2 		$339K Buy
+125,000
New +$302K ﹤0.01% 1216

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Nomura Holdings's MREO Position: Q2 2026 in Review

Nomura Holdings opened a new position in Mereo BioPharma (MREO) in Q2 2026: 104,361 shares worth $33.2K. The stake represents ﹤0.01% of the portfolio and ranks #1755 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in MREO as recently as Q3 2025.

Nomura Holdings first reported a position in MREO in Q2 2025 and has held it in 3 quarters since. The position peaked at $339K in Q2 2025. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Nomura Holdings held 104,361 shares of Mereo BioPharma worth $33.2K as of Q2 2026.
  • Mereo BioPharma was a new Nomura Holdings position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1755 holding.
  • Nomura Holdings first reported a position in Mereo BioPharma in Q2 2025 and has held it in 3 quarters since.
  • Nomura Holdings's Mereo BioPharma position peaked at $339K in Q2 2025.
  • 61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.